首页> 外文期刊>EMBO Molecular Medicine >Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
【24h】

Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment

机译:2型糖尿病初期肠道黏膜黏附和共生细菌易位:分子机制和益生菌治疗

获取原文
           

摘要

A fat?¢????enriched diet modifies intestinal microbiota and initiates a low?¢????grade inflammation, insulin resistance and type?¢????2 diabetes. Here, we demonstrate that before the onset of diabetes, after only one week of a high?¢????fat diet (HFD), live commensal intestinal bacteria are present in large numbers in the adipose tissue and the blood where they can induce inflammation. This translocation is prevented in mice lacking the microbial pattern recognition receptors Nod1 or CD14, but overtly increased in Myd88 knockout and ob / ob mouse. This ?¢????metabolic bacteremia?¢???? is characterized by an increased co?¢????localization with dendritic cells from the intestinal lamina propria and by an augmented intestinal mucosal adherence of non?¢????pathogenic Escherichia coli . The bacterial translocation process from intestine towards tissue can be reversed by six weeks of treatment with the probiotic strain Bifidobacterium animalis subsp. lactis 420, which improves the animals' overall inflammatory and metabolic status. Altogether, these data demonstrate that the early onset of HFD?¢????induced hyperglycemia is characterized by an increased bacterial translocation from intestine towards tissues, fuelling a continuous metabolic bacteremia, which could represent new therapeutic targets.
机译:富含脂肪的饮食会改变肠道菌群并引发低度炎症,胰岛素抵抗和2型糖尿病。在这里,我们证明,在糖尿病发作之前,仅在高脂饮食(HFD)一周后,在脂肪组织和血液中就可以大量存在活的共生肠道细菌炎。在缺少微生物模式识别受体Nod1或CD14的小鼠中可防止这种移位,但在Myd88基因敲除小鼠和ob / ob小鼠中明显增加。这种代谢性菌血症吗?其特征在于与来自固有层的树突状细胞共定位的增加和非致病性大肠杆菌在肠粘膜上的粘附性增加。通过益生菌动物双歧杆菌亚种治疗六周,可以逆转细菌从肠道向组织的移位过程。乳酸420,可改善动物的整体炎症和代谢状况。总而言之,这些数据表明,HFDαβ诱导的高血糖症的早期发作的特征在于细菌从肠向组织的易位增加,加剧了连续的代谢菌血症,这可以代表新的治疗靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号